Sitemap

Risk Factors of Razizi et al for a Patient in the Intensive Care Unit (ICU) Being Colonized with Extended-Spectrum beta-Lactamase (ESBL) Producing Enterobacteria

Prediction Rule of Yoon et al for Identifying a Patient Admitted to the Intensive Care Unit (ICU) Who May Be Colonized with Vancomycin-Resistant Enterococci (VRE)

Algorithm for Administering the Measles-Mump-Rubella (MMR) Vaccine in Children with Egg Allergy

Identification of Patients With a Higher Risk of Adverse Reaction to Japanese Encephalitis (JE) Vaccine

Categories of Adverse Events Associated with Vaccines

Vaccines Not Recommended for Immunocompromised Patients

Factors Suggesting a Causal Association Between a Vaccination and an Adverse Event

Method of James et al for Administering Influenza Vaccine to a Patient with Egg Allergy

Features of the Oculorespiratory Syndrome (ORS) Associated with Influenza Vaccination

Criteria of Scheifele et al for Evaluating an Injection Site Reaction Following Vaccination

Classification of Woo et al for Extensive Limb Swelling After Immunization

Evaluating a Patient for Local and Systemic Reactions to a Vaccine

Local Reactions to Live Measles Virus Vaccine in Previous Recipients of a Killed Measles Virus Vaccine

Risk of Disease Transmission Associated with a Needle-Free Jet Injector

Yellow Fever Vaccine-Associated Neurotropic Disease (YEL-AND, Postvaccinal Encephalitis)

Yellow Fever Vaccine-Associated Viscerotropic Disease (YEL-AVD, Postvaccinal Multiple Organ Failure)

Valid and Invalid Reasons of Lane et al for Not Vaccinating a Child

Vaccinating a Patient with Hemophilia or Other Serious Bleeding Disorder

Prevention of Secondary Injuries Associated with Syncope Following Vaccination

Recognition of a Syncopal or Vasovagal Reaction Associated with an Injection or Venipuncture

Cutaneous Pseudolymphoma at a Vaccination Site

Transmission of Yellow Fever By Breastfeeding After Administration of a Live Virus Vaccine to the Mother

Risk Factors of Klein et al for Apnea After Immunizing a Patient in the Neonatal Intensive Care Unit

Therapeutic Failure in the Treatment of Head Lice

Problems with Using Malathion for the Treatment of Lice

Measures to Prevent Serious Infection in the Asplenic Patient

Recommendations of Esteve et al for Vaccinating a Patient with Inflammatory Bowel Disease (IBD)

Recommendations of Kotton et al for Vaccinations in a Solid Organ Transplant Recipient

CDC Recommendations for Treatment with Interferon in Patients with Hepatitis C

Contraindications for Therapy with Interferon in Viral Hepatitis C

Recommendations for Vaccination Against Hepatitis A Virus

Recommendations for Postexposure Prophylaxis to Hepatitis A Virus

Recommendations for Vaccination Against Hepatitis B Virus

Initial Dosing of Copegus (Ribavirin) and Pegasys (Interferon alfa-2b) in the Therapy of Chronic Viral Hepatitis C

Adjusting the Dose of Copegus (Ribavirin) in a Patient with Chronic Viral Hepatitis C

Adjusting the Dose of Interferon alfa-2b in a Patient with Chronic Viral Hepatitis C

Algorithm of Fiore for Determining the Need for Immunoprophylaxis After Exposure to Food Prepared By a Food Handler with Hepatitis A

Primary Nonresponsiveness to Hepatitis B Virus Vaccine

Risk Factors of Bani-Sadr et al for Hepatic Decompensation During Interferon-Ribavirin Therapy in a Patient Coinfected with Hepatitis C Virus and HIV

Treatment Regimen of Keeffe et al for a Patient with Noncirrhotic HBeAg-Positive Hepatitis B Viral (HBV) Infection

Treatment Regimen of Keeffe et al for a Patient with Noncirrhotic HBeAg-Negative Hepatitis B Viral (HBV) Infection

Criteria of Mao et al for Treatment Response in Chronic HBeAg-Positive Viral Hepatitis B

Antitoxin and Immune Globulin Therapy in Botulism

Prophylactic Measures to Prevent Infection in Patients with Sickle Cell Disease

Evaluation of a Patient with HIV Virologic Failure for Drug Regimen Adherence

Indications for Starting Antiretroviral Therapy in a Patient with Chronic HIV Infection

Indications to Change an Antiretroviral Therapeutic Regimen

Hazards of Alcohol and Drug Abuse in a Patient Receiving Antiretroviral Therapy for HIV Infection

Risk Factors of Mugavero et al for a Patient with HIV Manifesting "No Show" Behavior

WHO Recommendations for Managing Toxicity Associated with Antiretroviral Drug Therapy

WHO Criteria for Treatment Failure in a Patient on a First-Line Antiretroviral Drug Regimen

Risk Score of Robbins et al for Predicting Virologic Failure for an HIV Outpatient

Drug Holiday (Structured Therapy Interruption) in a Patient with HIV Infection

Method of Wong-Beringer et al for Switching from Intravenous to Oral Antibiotic Dosing

Contraindications for the Use of Smallpox Live Vaccinia Virus Vaccine

Evaluation of the Patient Response to Smallpox Vaccination

Adverse Reactions Following Smallpox Vaccination

Contraindications for the Use of Smallpox Vaccine in Patients with Heart Disease

Vaccinia Gangrenosa (Vaccinia Necrosum, Progressive Vaccinia)

Indications for Passive Immunization with Varicella Zoster Immune Globulin (VZIG)

Recommendations for Active Varicella Vaccination

Indications and Contraindictions to Vaccination Against Herpes Zoster (Zostavax, Shingles Vaccine)

Recommendations for Vaccination to Measles, Mumps and Rubella

Contraindications and Precautions for Administration of Diphtheria-Tetanus-Pertussis (DTP) Vaccine

Tetanus Prophylaxis in Wound Management

Recommendations for Lyme Disease Vaccination

Management of a Patient with an Attached Tick

Management of a Patient with Carditis Associated with Lyme Disease

Recommendations for Vaccination Against Japanese Encephalitis (JE) Virus

The American Academy of Pediatrics (AAP) 1998 Recommendations for Palivizumab and RSV-IGIV to Prevent RSV Infection

Method of Robinson et al for Approaching a Patient with a Suspected Reaction to a Penicillin or Cephalosporin Antibiotic

Indications for Skin Testing with a Penicillin or Cephalosporin Antibiotic

Skin Test for Penicillin Allergy

Oral Desensitization Protocol of Gluckstein and Ruskin for a Patient with a Sensitivity Reaction to Trimethoprim-Sulfamethoxazole

Intravenous Desensitization Protocol of Ghosal and Taylor for Ceftazidime

Oral Protocol of Sullivan for Desensitization of a Patient with Allergy to a Beta-Lactam Antibiotic

Intravenous Desensitization Protocol of Gea-Banachloche and Metcalfe for Ciprofloxacin

Factors Associated with Fear of Injection or Fainting Afterwards

Criteria for the Diagnosis of Blood-Injection-Injury Specific Phobia

Reasons Identified by Meszaros et al for Why Some Parents Do Not Have Their Children Vaccinated Against Pertussis

Enabling and Preventing Factors of Friede et al for Vaccination in Developing Countries, with a Modification of the Adversity Index

Factors of Salmon et al for Identifying Parents Who May Refuse Vaccination for Their Children

Observations of Mercado on the Vaccination of a Patient with Systemic Lupus Erythematosus (SLE)

Indications for Prophylaxis Against Pneumocystis Carinii in a Patient with HIV Disease

Indications for Prophylaxis Against Mycobacterium avium-intracellulare (MAI) complex Infection in a Patient with HIV Disease

Indications for Prophylaxis Against Cytomegalovirus (CMV) Retinitis in a Patient with HIV Disease

Indications for Prophylaxis Against Cryptococcosis in a Patient with HIV Disease

Indications for Prophylaxis Against Toxoplasmosis in a Patient with HIV Disease

Indications for Prophylaxis Against Noncryptococcal Fungal Infections in a Patient with HIV Disease

Determining Vaccine Efficacy

Reasons Why a Vaccine May Not Be Effective in Preventing an Infection

Herd Immunity (Herd Protection)

Dosing Albendazole in Hydatid Disease and Neurocysticerosis

Dosing Thiabendazole for a Patient with a Nematode Infection

Dosing Ivermectin for a Patient with a Nematode Infection

Dosing Niclosamide for a Patient with an Intestinal Cestode (Tapeworm) Infection

Treatment of Toxocariasis with Visceral Larva Migrans

Therapeutic Strategies of Junghanss et al for Cystic Echinococcosis

Indications for Prophylaxis Against Pneumocytis Carinii in an HIV-Negative Patient

Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) with Trimethoprim Sulfamethoxazole (TMP-SMX)

Therapy of Pneumocystis Carinii Pneumonia (PCP) with Trimethoprim Sulfamethoxazole (TMP-SMX)

Vaccination and Travel Advice for a Person Making the Pilgrimage to Mecca (Hajj)

Dosing Trimethoprim-Sulfamethoxazole for Urinary Tract Infection, Acute Otitis and Other Infections in Children

Risk Factors for Nephrotoxicity Associated with Amphotericin B Deoxycholate Therapy

Protocol of Kiwan and Anaissie for Treating Invasive Pulmonary Aspergillosis

Indications of Anaissie et al for Antifungal Therapy in a Cancer Patient at Risk for Fungal Infection

Algorithm of Spellberg et al for Empirical Antifungal Therapy in a Patient with Known or Suspected Disseminated Candidiasis

Algorithm of Spellberg et al for Modifying Antifungal Therapy in a Patient with Disseminated Candidiasis

Risk Factors of Garey et al for Mortality in a Patient Treated with Fluconazole for Candidemia

Indications for the Use of Amphotericin B in Treating a Patient with Blastomycosis

Criteria for Apparent Cure in a Patient Treated for Paracoccidioidomycosis (South American Blastomycosis)

Risk Factors of Howard et al for Resistance of Aspergillus fumigatus to an Azole

Dose-Related Toxicity Associated with Itraconazole Therapy

Recommendations of Stevens et al for Prophylaxis Following a Laboratory Exposure to Coccidioides immitis

Factors of Ampel et al Influencing the Decision to Treat a Patient with Primary Pulmonary Coccidioidomycosis

Treatment Recommendations of Bariola et al for a Patient with Blastomycosis in the Central Nervous System

Differential Diagnosis of Apparent Failure with Antifungal Therapy

Criteria of Segal et al for Therapeutic Response in a Patient with Invasive Candidiasis

Rule of Paphitou et al for Risk-Stratified Prophylaxis Against Candida Infections of a Patient in the Surgical Intensive Care Unit (ICU)

Candidates for Postexposure Prophylaxis to Prevent Pertussis

The Standard Regimen for Selective Digestive Tract Decontamination

Determining If Methenamine Is Appropriate for Use as a Urinary Antiseptic Agent

Absolute and Relative Contraindications to Administration of the Live, Oral Rotavirus Vaccine

Immunoglobulin Administration Following Exposure to Measles

Contraindications and Precautions for Immunization with Yellow Fever Vaccine

Indications for Immunization with Yellow Fever Vaccine

Criteria for a Valid Yellow Fever Vaccination Certificate

Classification and Regression Tree (CART) Analysis of Moise et al for Predicting Response of a Nosocomial Staphylococcus aureus Pneumonia to Vancomycin

Expedited Partner Therapy (EPT) and Patient-Delivered Partner Therapy (PDPT)

Hazards of Expedited Partner Therapy (EPT)

Why a Patient with a Sexually-Transmitted Disease May Avoid Medical Treatment

Macrolide Resistance in Treponema pallidum (Syphilis)

Recommendations for Needle Length and Injection Site for an Intramuscular Injection

Abnormal Bacterial Morphology Associated with Antibiotic Therapy

Management Scheme of Montoya and Remington for a Pregnant Woman with Toxoplasmosis Acquired During Pregnancy

Recommendations of Kunin for the Management of a Catheter-Associated Urinary Tract Infection (CAUTI)

2002 IDSA Guidelines for Initial Management of a Cancer Patient with Neutropenia

2002 IDSA Guidelines for a Cancer Patient with Neutropenia Who Is Afebrile After Initial Empiric Antibiotic Therapy

2002 IDSA Guidelines for the Neutropenic Cancer Patient Who Is Still Febrile After 3 to 5 Days of Empiric Antibiotic Therapy

2002 IDSA Guidance on the Duration of Antibiotic Therapy in a Cancer Patient with Febrile Neutropenia

Indications of the IDSA for Addition of an Antibiotic Active Against a Gram-Positive Organism to an Empiric Regimen for Neutropenia with Fever

Indications for Administration of a Typhoid Fever Vaccine

Administration of the Capsular Vi Polysaccharide Vaccine for Prevention of Typhoid Fever

Administration of the Oral Ty21a Vaccine for Prevention of Typhoid Fever

Empirical Outpatient Therapy for a Patient with Community Acquired Pneumonia Based on the IDSA/ATS Guidelines

Criteria of van der Valk for a Patient with an Exacerbation of Chronic Obstructive Pulmonary Disease Who Does Not Require Antibiotic Therapy

Delayed Defervescence in a Patient Being Treated for a Lung Abscess

Myospherulosis

Possible Infectious Complications of a Rat Bite

Criteria for Appropriate vs Inappropriate Initial Antimicrobial Therapy of a Serious Bacterial Infection

Criteria of Cadieux et al for Inappropriate Antibiotic Prescribing in Primary Care

Algorithm of Schuetz et al for Using the Serum Procalcitonin Concentration to Guide Antibiotic Therapy: Low Risk Infection

Algorithm of Schuetz et al for Using the Serum Procalcitonin Concentration to Guide Antibiotic Therapy: Moderate Risk Pneumonia

Algorithm of Schuetz et al for Using the Serum Procalcitonin Concentration to Guide Antibiotic Therapy: Severe Infection or Sepsis

Guidelines of Nobre et al for Using the Serum Procalcitonin Concentration to Treat a Patient with Sepsis

Selection of Antibiotics to Treat Sepsis Caused By Vibrio Vulnificus

Indications of a Therapeutic Response in a Patient with Giardiasis

Reasons for Giardiasis to Be Refractory to Therapy

Antiviral Drug Resistance in Cytomegalovirus (CMV)

Monitoring the Response of Osteomyelitis to Antibiotic Therapy

Recommendations of Tarr et al for Managing a Patient with Hemolytic Uremic Syndrome (HUS) Caused By Shiga Toxin-Producing Escherichia coli

Criteria of Tarr et al for Resolution of Hemolytic Uremic Syndrome (HUS) Caused By Shiga Toxin-Producing Escherichia coli

Initial Intensive Therapy for Meliodosis

Switching to Meropenem During Initial Intensive Therapy of Meliodosis

Oral Eradication Therapy of Meliodosis with Amoxicillin-Clavulanate

Oral Eradication Therapy of Meliodosis with Trimethoprim-Sulfamethoxazole

Criteria of Hoelzer et al for When to Stop Antibiotic Therapy in a Child with Complicated Appendicitis

CDC Recommendations for When to Consult an Expert for HIV Postexposure Prophylaxis (PEP)

NICE Recommendations for Management of a Pediatric Patient with Gastroenteritis

Score of Aliberti et al for Identifying a Patient with Community-Acquired Pneumonia at Risk for a Multi-Drug Resistant Pathogen

Risk Factors of Shindo et al for Community-Acquired or Healthcare-Associated Pneumonia with a Drug-Resistant Pathogen (DRP)

Discolored Leg Syndrome (DLS) Following Administration of the DTP-IPV-Hib Vaccine to an Infant

Vaccination Against Viral Hepatitis A and B in a Patient with Chronic Liver Disease (CLD)

Impaired Antibody Response to Vaccination During Rituximab or Abatacept Therapy

Antibody Response (AR) to Vaccination

Immontherapeutic Vaccine for a Patient with Severe Pythiosis

Management of a Patient with Pythiosis

Errors in the Administration of Oral Live Rotavirus Vaccine

Findings Indicative of Treatment Failure in a Patient Treated for Syphilis

Safety Assessment of a Probiotic and Qualified Presumption of Safety (QPS)

CDC Recommendations for Vaccination of a Patient with Cochlear Implants

Ways to Improve the Vaccination Rates for Hospitalized Patients

World Health Organization (WHO) Categories of Contact with a Potentially Rabid Animal

Factors of Wilde That Contribute to a Failure of Post-Exposure Rabies Prophylaxis

Recommendations for Administering Both 13- and 23-Valent Pneumococcal Vaccines to a Patient >= 65 years of Age

CART Model of Moore et al for Predicting Failure of Vancomycin Therapy for MRSA Bloodstream Infection

Guillain-Barre Spectrum Disorders (Guillain-Barre Syndrome, Miller Fisher Syndrome, Bickerstaff Syndrome) Associated with Vaccination

Deciding Whether to Test for Immunity Before Vaccination or Not

Primary and Secondary Measles Vaccine Failures: Measurement of IgG Avidiity and IgM Antibodies

Score of Stajadinovic et al for Predicting Treatment Failure in a Patient with a Suppurative Kidney Infection

Factors Associated with Substantial Risk for Acquiring HIV Infection

CDC Guidelines for Preexposure Prophylaxis to Prevent HIV Infection: Male Who Has Sex with Males (MSM)

CDC Guidelines for Preexposure Prophylaxis to Prevent HIV Infection: Heterosexual Activity

CDC Guidelines for Preexposure Prophylaxis to Prevent HIV Infection: Injection Drug User (IDU)

Risk Factors of Sanchez et al for Spread of Multi-Drug Resistant (MDR) Klebesiella pneuomoniae in Critically-Ill Burn Patients

Score of Martin et al for Distinguishing Carbapenem-Resistant from Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae

Risk Factors of Schwaber et al for Hospital Acquisition of Carbapenem-Resistant Klebsiella pneumoniae

Risk Factors of Fu et al for Extensive Drug Resistance and Mortality in an Older Adult with Acinetobacter baumannii Bacteremia

Risk Factors for a Burn Patient Becoming Colonized with Vancomycin-Resistant Enterococci (VRE)

Clinical Rule of Ma et al for Predicting Antibiotic-Resistant Bacterial Pneumonia in an Older Chinese Patient

Clinical Decision Rule of Faine et al for Identifying an Adult with an Antimicrobial-Resistant Urinary Pathogen in the Emergency Department

Recommendations of Bradley et al for Minimizing Antibiotic Resistance

Model of King et al for Predicting Oral Antibiotic Treatment Failure of a Child with Rapid Breathing Community-Acquired Pneumonia

Criteria of King et al for Failure of Oral Antibiotic Therapy of a Child with Rapid Breathing Community-Acquired Pneumonia

Decision to Continue Parenteral Antibiotic Therapy for a Young Pediatric Patient with Community-Acquired Pneumonia (CAP)

Duration of Antibiotic Therapy for a Young Pediatric Patient with Community-Acquired Pneumonia (CAP)

Recommendations of Bradley et al for the Prevention of Community-Acquired Pneumonia (CAP) in an Infant

Factors Influencing the Choice of Antibacterial Therapy in an Infant or Child with Community-Acquired Pneumonia (CAP)

Clinical Follow-up for Expected Response to Antibiotic Therapy for an Infant or Child with Community-Acquired Pneumonia (CAP)

Duration of Antibiotic Therapy for a Young Pediatric Patient with Community-Acquired Pneumonia (CAP) and Parapneumonic Effusion or Empyema

Reducing Recurrence of Clostridium difficile Infection with Bezlotoxumab (Zinplava)

Model of Park et al for Identifying a Patient with Healthcare-Associated Pneumonia with an Antibiotic-Resistant Pathogen

Drug Resistance in Pneumonia (DRIP) Score of Webb et al for Antibiotic Resistance in Community-Onset Pneumonia

Risk Factors of Nicoletti et al for Ciprofloxacin-Resistant Escherichia coli Urinary Tract Infection (UTI) in a Tertiary Care (University) Hospital

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Local Reaction

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Vital Signs

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Systemic Reactions

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Renal Reactions

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Coagulopathy

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Hematologic Reactions

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Basic Chemistry Tests

FDA Toxicity Grading Scale for Preventive Vaccine Trials: Additional Chemistry Tests

Criteria of Walter et al for Response to Initial Antibiotic Therapy in a Patient with Early-Onset Acute Stroke-Associated Pneumonia (SAP)

Predictors of da Silva et al for Adverse Drug Effects in a Patient Treated with Benznidazole for Chaga's Disease (Trypanosoma cruzi)

Clinical Decision Tree of Goodman et al for Bacteremia Caused By an Extended Spectrum Beta-Lactamase (ESBL) Producing Bacteria

Score of Schreiber et al for a Antibiotic-Resistant Pathogen in a Patient with Severe Pneumonia and Respiratory Failure

GSDCS Prediction Score of Vasudevan et al for Nosocomial Multi-Drug Resistant (MDR) Gram Negative Bacilli Infections in a Patient in the Intensive Care Unit (ICU)

Clinical Risk Score of Augustine et al for Predicting Extended-Spectrum beta-Lactamase Producing Enterobacteriaceae (ESBLE) in a Bloodstream Infection

Recommendations of the CADTH for Treating Chronic Viral Hepatitis Genotypes 2 to 4 with Direct-Acting Agents

Recommendations of the CADTH for Treating Chronic Viral Hepatitis Genotype 1 with Direct-Acting Agents

Algorithm of Huang et al for Using Procalcitonin to Guide Antibiotic Therapy in a Patient with Secondary Peritonitis

Recommendations for Use of the Cholera Vaccine CVD 103-HgR

Recommendations of Augustine et al for Treating a Bloodstream Infection (BSI) Caused by an Enterobacteriaceae

Clinical and Laboratory Findings of Stone et al Associated with Low Risk of Recurrent Surgical Infection After Discontinuation of Antibiotic Therapy

Algorithm of Halilovic and Heintz for Dosing Antibiotics in a Patient with Cirrhosis

Indications for Therapeutic Drug Monitoring (TDM) of an Antibiotic

Indications for Therapeutic Drug Monitoring of Antituberculous Therapy

Factors of Lane et al Influencing Outpatient versus Inpatient Antibiotic Therapy for an Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Indications of Liu et al for Antibiotic Therapy Following Incision and Drainage of an Abscess Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus (MRSA)

Criteria of Schroeck et al for Appropriate Antibiotic Therapy in a Patient with Pharyngitis

Criteria of Schroeck et al for Inappropriate Antibiotic Therapy in a Patient with Bronchitis

Criteria of Schroeck et al for Appropriate Antibiotic Therapy in a Patient with Sinusitis

Criteria of Schroeck et al for Appropriate Therapy in a Patient with Nonspecific Upper Respiratory Tract Infection (URTI)

Risk Factors of Schroeck et al for Inappropriate Antibiotic Therapy in a Patient with an Upper Respiratory Tract Infection

Management Protocol of Claeys et al for a Patient with Skin and Skin Structure Infection Guided by the CREST Scoring System

Paradoxical (Unexplained) Clinical Deterioration in a Patient Being Treated for Tuberculosis

Adverse Effects of BCG Vaccine to Prevent Tuberculosis

Benefits of Prophylactic Antibiotics for a Patient with Acute Variceal Hemorrhage and Cirrhosis

Intravenous Antibiotics and Addiction Team, IVAT) 9 Point Assessment of Rolfe et al for Identifying an Injection Drug User Who Can Receive Parenteral Antibiotics As an Outpatient

Predictors of Sowunmi et al for Failure of Chloroquine Therapy of Plasmodium falciparum Malaria in a Region of Chloroquine Resistance

Score of Ciobotaro et al for Predicting Persistent Carriage of Carbapenem-Resistant Enterobacteriaceae

Risk Factors of Gao et al for Antibiotic Resistant Pseudomonas aeruginosa in a Patient with Bronchiectasis

Model of Johnson et al for Predicting Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae at Hospital Admission (Duke Model)

Risk Factors of Garcia-Vidal et al for Multi-Drug Resistant Pseudomonas aeruginosa Causing Bloodstream Infection (BSI) in a Patient with Acute Leukemia

Difficult to Treat Resistant (DTR) Gram-negative Bacteria

Risk Factors of Tseng et al for Predicting Colonization with Multidrug-Resistant (MDR) Gram-Negative Bacteria of a Patient Being Admitted to the Hospital

Risk Factors of Bhargava et al for Colonization with Carbapenem-Resistant Enterobacteriaceae of a Patient Having Contact with a Long-Term Acute Care Facility

Vaccination-Associated Seizures in a Patient with Mutations in SCN1A

Adverse Effects of Therapy for the Diagnosis of Chronic Lyme Disease

STARWAVe Pneumonic of Hay et al for Improved Use of Antibiotic Use in a Child with an Acute Respiratory Infection and Cough

Antibiotic Discontinuation for a Respiratory Infection Associated with a Positive Respiratory Viral Panel and Low Serum Procalcitonin Concentration

Criteria for Clinical Failure for a Patient Who Has Been Treated for an Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Criteria of Nathwani et al for Therapeutic Success for a Patient with Acute Bacterial Skin and Skin Structure Infection (ABSSSI) to Antibiotic Therapy

Recommendations of Walsh et al for Acne Management with Avoidance of Antibiotic Resistance

Predictors of Yadav et al for Oral Antibiotic Failure of Nonpurulent Skin and Soft Tissue Infections

Indications for Receipt of the Human Papillomavirus (HPV) Vaccine

Antibiotic Spectrum Index (ASI)

CDC Checklist for a Hospital Antibiotic Stewardship Program

Score of Rattanaumpawan et al for a Fluoroquinolone-Resistant Urinary Tract Infection (UTI) Caused by Gram-Negative Bacteria

Risk Factors of Tsai et al for Multidrug-Resistant Gram-negative (MDR GN) Bacteremia in the NICU

Sciatic Nerve Damage After Vaccine Injection into the Buttocks of an Infant or Child

Failures in Maintaining Temperature During Vaccine Storage

Risk Factors of Chemaly et al for Cytomegalovirus (CMV) Antiviral Resistance in Transplant Recipients

Criteria of Chemaly et al for a Refractory Cytomegalovirus (CMV) Infection in Transplant Recipients

Clinical Risk Prediction Tool of Nochaiwong et al for Antibiotic Treatment Failure in a Patient with Peritoneal Dialysis Related Peritonitis

Risk Factors of Roldan-Masedo et al for Gentamicin-Resistant Escherichia coli Urinary Tract Infection (UTI) in Children

Silver Resistance

Bedside Risk Score of Miller and Johnson for Carbapenem-Resistant Enterobacteriaceae

Risk Factors of Blanco et al for Colonization With Multidrug-Resistant Acinetobacter baumannii on Admission to the Intensive Care Unit (ICU)

Multidrug-Resistance Pulmonary Tuberculosis (MDR-TB) Score of Martinez et al

Predictors of Kliiman and Altraja for Poor Treatment Outcome in Drug-Resistant Pulmonary Tuberculosis

Predictors of Blondal et al for Recurrence of Multidrug-Resistant or Extensively Drug-Resistant Tuberculosis

Risk Factors of Dirajlal-Fargo et al for Carbapenem-Resistant Enterobacteriaceae (CRE) in a Pediatric Patient

Sweet's Syndrome Associated with Vaccination

Hearing Loss Following Receipt of the Measles-Mumps-Rubells (MMR) Vaccine

Score of Nesheim et al for Antiretroviral Therapy of an HIV-Exposed Infant

Administration of Granulocyte Colony Stimulating Factor (G-CSF) in a Pediatric Patient with Neutropenia

Management of a Research Laboratory Worker with a Macaque-Related Injury and Possible Exposure to Herpes B Virus

Criteria of Marschall et al for Inadequate Empirical Antibiotic Therapy of Gram-negative Bacteremia

Recommendations for HPV Vaccination in an Adult

Model of Frazee et al for Predicting Vancomycin Trough Levels

2019 Recommendations for Pneumococcal Vaccination in an Older Adult

Risk Assessment Stratification Protocol (RASP) for a Possible Exposure to HIV

Risk Factors of Keller et al for Adverse Drug Events for a Patient Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)

Criteria of Patel et al for Suitability of Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT)

Categories for Outcomes Associated with Outpatient Parenteral Antibiotic Therapy (OPAT)

Predictors of Schmidt et al for Unplanned Hospitalization for an Adult Receiving Outpatient Parenteral Antibiotic Therapy (OPAT)

Model of Ben Ayed et al for Community-Acquired Urinary Tract Infection (CUTI) Caused By a Multidrug-Resistant Enterobacteriaceae

Antibiotic Resistance in Helicobacter pylori

Risk Factors of Li et al for Colonization of a Pediatric Patient with an Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamase (ESBL) on Admission to the Intensive Care Unit (ICU)

Score of Gonzalez del Castillo et al for Multi-Drug Antibiotic Resistance in an Emergency Room Patient

Risk Factors of Kliiman and Altraja for Resistant Pulmonary Tuberculosis

Models of Rottier et al for Predicting Bacteremia Caused by a Third-Generation Cephalosporin-Resistant Enterobacteria: Community Onset

Models of Rottier et al for Predicting Bacteremia Caused by a Third-Generation Cephalosporin-Resistant Enterobacteria: Hospital Onset

BE3A Score of El-Sherif et al for Response to Direct-Acting Antiviral Therapy for Hepatitis C

Models of Andriulli et al for Response to Therapy with Peginterferon Plus Ribavirin for Viral Hepatitis C: Model for Rapid Viral Response (RVR)

Models of Andriulli et al for Response to Therapy with Peginterferon Plus Ribavirin for Viral Hepatitis C: Model for Sustained Viral Response (SVR)

Criteria of Akhloufi et al for Switching from Intravenous to Oral Antibiotic Therapy

PEN-FAST Score of Trubiano et al for Evaluating a Patient for Penicillin Allergy

Adverse Immune-Mediated Events Following Chemotherapy for Lymphatic Filariasis

EQUAL Score for Mucomycosis Management

Delayed Antibiotic Therapy of a Urinary Tract Infection (UTI) in a Febrile Child

Risk Factors of Guarana et al for Shock and Early Death in a Hematology Patient with Febrile Neutropenia

American Thoracic Society (ATS) Management Strategy for an Adult with Healthcare-Associated Pneumonia

Causes of Nonresponse to Initial Antibiotic Therapy for Healthcare-Associated Pneumonia (HAP)

Protocol of Singh et al for Managing a Patient in the Intensvie Care Unit with a Pulmonary Infiltrate

Model of Mehr et al for Predicting Antibiotic Therapy of a Nursing Home Resident with Pneumonia and Dementia

Decision Models of Fischer et al for Macrolide Therapy in a Child with Community-Acquired Pneumonia

Criteria for Switching from Intravenous to Oral Antibiotic Therapy for an Adult with Community-Acquired Pneumonia (CAP)

Risk Factors of Micek et al for Ineffective Empiric Therapy of Gram-Negative Sepsis

Serum Procalcitonin and Systemic Bacterial Infection in a Febrile Patient with an Autoimmune Disease

Protocol of Mintegi et al for Managing a Febrile Infant Under 3 Months of Age Without Antibiotics or Lumbar Puncture

Simplified Method of Gross et al for Dosing Aztreonam in a Patient with End-Stage Renal Disease

Conditions That May Be Suitable for Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT)

Bedside Instrument of Zilberberg et al for Carbapenem Resistant Gram-Negative Pathogens in a Complicated Urinary Tract Infection (UTI)

Model of Wang and Tu for Predicting Multidrug-Resistant Tuberculosis

Gianotti-Crosti Syndrome (Papular Acrodermatitis) Following Anti-Viral Vaccination

Protocol of Stevenson et al for Pencillin Allergy in an Outpatient

Predictors of Mohamed et al for True Penicillin Allergy

Vaccine Confidence Scale

Vaccine Conspiracy Beliefs Scale (VCBS)

Predictors of Roger et al for Unnecessary Antibiotic Therapy in a Hospitalized Patient with Possible Infection

Risk Factors of Gooiker et al for Excess 1-Year Mortality After Curative Surgery for Colorectal Cancer

Protocol of Oda et al for Dosing Vancomycin to Achieve a Target Area Under the Concentration-Time Curve

Equation of Smit et al for Dosing Tobramycin

Clinical Prediction Model of Peetluk et al for Unsuccessful Outcomes in a Patient Treated for Pulmonary Tuberculosis

Recommendations of Ellsbury et al for Pneumococcal Vaccination of a Traveler

Antibiotic Resistance in Neisseria meningitidis Serogroup Y

CarbaSCORE of Teysseyre et al

Risk Factors of Pomba et al for Antibiotic-Resistant Bacteria in a Companion Animal

Clinical Risk Score of Ma et al for Antibiotic-Resistant Bacterial Pneumonia in an Elderly Chinese Adult

Score of Jeong et al for Predicting Antibiotic-Resistant Pneumonia in an Immunocompetent Adult Acquired Outside of the Hospital

CREP Risk Prediction Model of Song and Jeong for Carbapenem-Resistant Enterobacteriaceae Colonization of a Patient in an Intensive Care Unit (ICU)

Risk Factors of Trinh et al for Multidrug-Resistant Pseudomonas aeruginosa Pneumonia in a Patient in the Intensive Care Unit (ICU)

COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia (Vaccine-Induced Thrombocytopenia and Thrombosis, VITT)

Common Terminology Severity Scale for a Local Vaccine Site Adverse Event

Myocarditis Associated with COVID-19 Vaccination

Vaccine Site Appearance Grading Scale (VSAGS)

Shoulder Injury Related to Vaccine Administration (SIRVA)

Conditions Considered Serious Adverse Events in the Vaccine Adverse Event Reporting System (VAERS)

Vaccine Injury Table

Guillain-Barre Syndrome Following COVID-19 Vaccination

Misdiagnosis of a Vaccination-Related Adverse Effect

Indications and Contraindications for Vaccination with Shingrix (Zoster Vaccine Recombinant)

Post-Ivermectin or Post-Diethylcarbamazine Loa Loa Encephalopathy

Risk Factors of Ostrosky-Zeichner et al for Fluconazole Failure in a Patient with Candidemia

PRoFeSs Score of Pereira et al for Early Treatment Failure in Severe Community-Acquired Pneumonia

Clinical Tool of Mamtani et al for Predicting Treatment Failure for a Child Being Treated for Pneumonia

Nomogram of Cheng et al for Predicting Refractory Mycoplasma pneumoniae Pneumonia in a Child

Risk Factors of O'Brien et al for Failure of Antibiotic Therapy for a Patient with Buruli Ulcer

Ranking of Weiss et al for De-Escalation of Beta-Lactam Antibiotics

Nomogram of Batchelder et al for Dosing Vancomycin in an Obese Adult (Cone Health Modified Vancomycin Nomogram)

Method of Smit et al for Dosing Gentamicin in an Obese Adult with Normal Renal Function

Risk Factors for 13-Valent Conjugated Pneumococcal Vaccine Failure in a Pediatric Patient

Vancomycin-Resistant Enterococcus Bloodstream Infection Score of Webb et al

Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT)

Score of Meier and Berger for Identifying a Nonresponder to Hepatitis B Vaccination

TREAT-B Score for When to Treat Viral Hepatitis B (HBV)

Score of Rincon-Lopez et al for Guiding Antibiotic Therapy in a Child with Sickle Cell Disease and Fever

Risk Factors of Chu et al for Initially Inappropriate Antibiotic Therapy of Neonate with Gram-Negative Bacteremia

Criteria of Garber et al for Restricting Empiric Antibiotic Therapy to Prevent Early-Onset Infection in a Preterm Neonate

Indications for Dengue Vaccination in a Pediatric Patient

Risk Prediction Model of Durojaiye et al for 30-Day Unplanned Hospitalization for a Patient Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)

Clinical Prediction Tool of Wang et al for Extended-Spectrum Beta-Lactamase-Producing Enterobacterales (ESBL-EB) Bloodstream Infection in Solid Organ Transplant Recipients

Non-Infectious Complications of Bacillus Calmette-Guerin (BCG) Therapy for Bladder Cancer

Vaccine-Associated Leukocytoclastic Vasculitis (LCV)

Exacerbation of the Systemic Capillary Leak Syndrome (SCLS) After COVID-19 Vaccination

Risk Factors of Aussy et al for Treatment Failure for an Ambulatory Patient with Scabies

Survey of Opel et al for Identifying a Vaccine-Hesitant Parent

EQUAL Trichosporon Score 2022

Criteria of Dinh et al for Antibiotic Treatment Failure in Community-Acquired Pneumonia

Risk Factors of Montravers et al for Therapeutic Failure or Death in Post-Operative Peritonitis

Risk Factors of Lorton for Suboptimal Initial Management of a Severe Community-Onset Pediatric Bacterial Infection (COSBI)

Algorithm of Haukoos et al for HIV Pre-Exposure Prophylaxis

Adrenal Insufficiency Following Vaccination

Predictors of Starrels et al for Inappropriate Antibiotic Use by an Intravenous Drug Abuser

Model of Buendia and Feliciano-Alfonso for Inappropriate Prescribing for Acute Bronchiolitis

Classification of Wu et al for Appropriate Antibiotic Use with Infections Encountered in Primary Care

Criteria of Davar et al for Switching from an Intravenous to Oral Antibiotic Regimen

Prognostic Factors of Fisher et al for a Solid Organ Transplant Recipient with Ganciclovir Resistant Cytomegalovirus (CMV)

Risk Factors of Horton et al Associated with Treatment Failure of Fracture-Related Infections

Factors of Pelegrin et al for Treatment Failure of a Ventriculoperitoneal (VP) Shunt Infection

Indications and Contraindications for Mpox JYNNEOS Vaccination

Observations of Zahar et al for Appropriate and Inappropriate Prescribing of Aminoglycosides

Inappropriate Malaria Chemoprophylaxis

Risk Factors of Jacob et al for Antibiotic Resistance in a Patient with Acute Pyelonephritis in India

Predictors of Gudiol et al for a Bloodstream Infection with a Multidrug Resistant Pseudomonas aerugnosa in a Neutropenic Patient

Score of Moghnieh et al for Carbapenem Resistance in an Inpatient with a Third Generation Cephalosporin Resistant Enterobacterales

Heteroresistance

Risk Factors for Multidrug Resistant Pseudomonas aeruginosa Infection in an Immunocompromised Patient

Risk Factors of Kandemir et al for Multi-Drug Resistant (MDR) Bacteria Infecting a Diabetic Foot

Score of Hernandez-Jimenez et al for Predicting Infection with a Multidrug-Resistant Pseudomonas aeruginosa

Algorithm of Wood et al for Managing a Patient with a Possible Hypersensitivity Reaction to a Vaccine

Meningitis Following After Measles, Mumps, and Rubella (MMR) Vaccine

CDC Recommendations for Respiratory Syncytial Virus (RSV) Vaccination of an Older Adult

Impaired Vaccine Response to COVID-19 Vaccination in a Patient Treated with Rituximab

Predictors of Klastersky et al for Outpatient Oral Antibiotic Therapy of a Cancer Patient with Febrile Neutropenia

Predictors of Mandell et al for Nonresponse of an Adult with Community-Acquired Pneumonia (CAP) to Antibiotic Therapy

Predictors of Basnet et al for Treatment Failure in a Young Child Hospitalized for Severe Pneumonia

Pros and Cons of Antibiotic Therapy in a Patient with Dementia

Reasons of Bradley et al for Readmission for a Patient Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)

Clinical Prediction Score of Maskov et al for Identifying a Patient with Pseudomonas aeruginosa Pneumonia

ICU-CARB Score of Dai et al for Predicting Carbapenem-Resistant Gram-Negative Bacteria Carriage in the Intensive Care Unit (ICU)

Score of Gomes et al for Predicting Carbapenem-Resistant Gram-Negative Bacteremia in a Hospitalized Patient

Clinical Risk Score of Herrera et al for Carbapenem-Resistant Enterobacterales Bacteremia in a Patient with Cancer or Hematopoietic Stem Cell Transplantation

Aplastic Anemia Following COVID-10 (SARS-CoV-2) Vaccination

Acute Disseminated Encephalomyelitis (ADEM) Following Vaccination

HePAA Score of Geeratragool et al for Identifying a Patient with Chronic Hepatitis B Who Is a Candidate for Therapy

REACH-B Score of Yang et al in a Patient with Chronic Hepatitis B

Equations of Van Mulder et al for Skin Thickness and Intradermal Injections in Children

Decision Tree of Takacs et al for Identifying a Pediatric Patient with Tonsillopharyngitis Who Does Need Antibiotic Therapy

Model of Stocker et al for Duration of Antibiotic Therapy in a Neonate with Possible Early-Onset Sepsis

Score of Mao et al for Predicting Treatment Failure of Peritoneal Dialysis-Associated Peritonitis (PDAP)

Discontinuation of PrEP

Decision Tree of Goldberg et al for Discontinuation of Antibiotics 24 Hours After an Initial Work-Up for a Neonate with Late-Onset Sepsis

Protocol of Sathitakorn et al for Antibiotic Discontinuation in a Patient with Moderate to Severe COVID-19 Pneumonia

Vancomycin Dosing Nomogram of Baptista et al for an Adult in the Intensive Care Unit (ICU)

Antibiotics, Vaccines & Prophylaxis